- LysoPC(14:0/0:0)
-
- $39.00 / 5mg
-
2026-04-21
- CAS:20559-16-4
- Min. Order:
- Purity: 99.85%
- Supply Ability: 10g
|
| | 1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE Basic information |
| Product Name: | 1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | | Synonyms: | L-GAMMA-MYRISTOYL-ALPHA-LYSOLECITHIN;L-ALPHA-LYSOPHOSPHATIDYLCHOLINE, MYRISTOYL;LYSOLECITHIN, MYRISTOYL;1-MYRISTOYL-2-HYDROXY-SN-GLYCERO-3-PHOSPHOCHOLINE;1-MYRISTOYL-2-HYDROXY-SN-GLYCERO-3-PHOSPHATIDYLCHOLINE;1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE;3-SN-LYSOPHOSPHATIDYLCHOLINE, 1-MYRISTOYL;14:0 LYSO PC | | CAS: | 20559-16-4 | | MF: | C22H46NO7P | | MW: | 467.58 | | EINECS: | | | Product Categories: | | | Mol File: | 20559-16-4.mol |  |
| | 1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE Chemical Properties |
| Melting point | >142°C (dec.) | | storage temp. | −20°C | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | color | White to Off-White | | InChI | InChI=1/C22H46NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-22(25)28-19-21(24)20-30-31(26,27)29-18-17-23(2,3)4/h21,24H,5-20H2,1-4H3/t21-/s3 | | InChIKey | VXUOFDJKYGDUJI-DLINEHSKNA-N | | SMILES | P([O-])(=O)(OCC[N+](C)(C)C)OC[C@H](O)COC(=O)CCCCCCCCCCCCC |&1:12,r| |
| WGK Germany | 3 | | F | 10 | | Hazard Classifications | Acute Tox. 3 Inhalation
Acute Tox. 4 Oral
Aquatic Chronic 3
Carc. 2
Eye Irrit. 2
Repr. 2
Skin Irrit. 2
STOT RE 1
STOT SE 3 |
| | 1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE Usage And Synthesis |
| Description | 1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE is a lysophospholipid (LyP), which is a monoglycerophospholipid in which the phosphorylcholine moiety occupies the glycerol substitution site. LysoPC(14:0/0:0) has a potent antispasmodic effect. | | Physical properties | 1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE is a Solid,it can insoluble in water. | | Uses | 1-Myristoyl-sn-glycero-3-phosphocholine is a derivative of sn-Glycero-3-phosphocholine (G598700) and can be used as a biomarker in biological studies. | | Definition | ChEBI: 1-myristoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine 14:0 in which the acyl group specified is myristoyl. The major species at pH 7.3. It is a lysophosphatidylcholine 14:0, a 1-O-acyl-sn-glycero-3-phosphocholine and a tetradecanoate ester. | | in vivo | Of the saturated fatty acid-containing L-α-lysolecithins (LPC), palmitoyl-LPC shows the strongest antispasmodic effect against acetylcholine- or histamine-induced guinea pig ileum contraction; the order of potency of the others is (LysoPC(14:0/0:0)) myristoyl- > stearoyl-, lauroyl- > decanoyl-LPC. Incorporation of a cis-double bond into the C18 fatty acid chain of LPC resulted in a slight decrease of the antispasmodic effect[1]. | | IC 50 | Human Endogenous Metabolite |
| | 1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE Preparation Products And Raw materials |
|